0001104659-24-072998.txt : 20240618
0001104659-24-072998.hdr.sgml : 20240618
20240618212249
ACCESSION NUMBER: 0001104659-24-072998
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230314
FILED AS OF DATE: 20240618
DATE AS OF CHANGE: 20240618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Neill Vincent
CENTRAL INDEX KEY: 0001672718
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38410
FILM NUMBER: 241053833
MAIL ADDRESS:
STREET 1: 2150 WOODWARD ST., SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78744
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BioXcel Therapeutics, Inc.
CENTRAL INDEX KEY: 0001720893
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 821386754
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 555 LONG WHARF DRIVE
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
BUSINESS PHONE: 203-643-8060
MAIL ADDRESS:
STREET 1: 555 LONG WHARF DRIVE
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
4/A
1
tm2417544-3_4aseq1.xml
OWNERSHIP DOCUMENT
X0508
4/A
2023-03-14
2023-03-16
0
0001720893
BioXcel Therapeutics, Inc.
BTAI
0001672718
O'Neill Vincent
C/O BIOXCEL THERAPEUTICS, INC.
555 LONG WHARF DRIVE, 12TH FLOOR
NEW HAVEN
CT
06511
0
1
0
0
See Remarks
0
Common Stock
3158
D
Restricted Stock Units
Common Stock
0
0
D
Stock Option (Right to Buy)
Common Stock
0
0
D
This amendment is being filed to correct the amount previously reported in the Form 4 filed on March 16, 2023 (the "Original Form 4") that inadvertently reported an award of (i) 9,000 restricted stock units ("RSUs") and (ii) options to purchase 32,000 shares of the Issuer's common stock (the "Options"). The Reporting Person was not granted such RSUs and Options and does not beneficially own any shares underlying the awards reported on the Original Form 4.
Executive Vice President, Chief of Product Development and Medical Officer
/s/ Richard Steinhart, as Attorney-in-Fact for Vincent O'Neill
2024-06-18